文献速递外周动脉疾病

慢性肢体威胁性缺血患者经皮深静脉动脉化的适用性

Eligibility of Patients with Chronic Limb Threatening Ischemia for Deep Venous Arterialization.
PubMed 文献 · Ann Vasc Surg · 2022-05-16

本研究回顾100例因外周动脉疾病行重大截肢患者的病历,由两名血管外科医师评估截肢前≤6个月的血管造影,按GLASS分级将患者分为经皮深静脉动脉化(pDVA)理想、可能或不适用候选者。结果显示23.2%的肢体为pDVA候选者,14.7%的肢体可能受益,33%的截肢为临床判断无法挽救的慢性肢体威胁性缺血。

要点

  • 在因外周动脉疾病行重大截肢的患者中,23.2%的肢体血管造影适合pDVA。
  • pDVA候选者截肢前干预次数显著少于非候选者(1.50±0.73 vs 2.61±2.57,P=0.007)。
  • pDVA候选者踝下GLASS分级更高、股腘GLASS分级更低,但GLASS分期无显著差异。

核心结论

  • 在考虑血运重建的患者中,23.2%的肢体血管造影适合pDVA,14.7%的肢体可能受益于pDVA作为保肢新治疗方式。
  • 33%的重大截肢是因临床判断为无法挽救的慢性肢体威胁性缺血而实施。

研究设计与样本

  • 回顾100例连续外周动脉疾病患者的病历,共106条肢体行重大截肢。
  • 由两名血管外科医师评估截肢前≤6个月内完成的血管造影,按GLASS分级将患者分类为pDVA理想、可能或不适用候选者。

主要发现

  • 106条肢体中,35条(33%)因感染(n=14)、晚期组织缺损(n=10)、血运重建失败(n=8)、晚期肢体缺血(n=2)和拒绝血运重建(n=1)未在截肢前≤6个月内行血管造影。
  • 最终分析68例患者的69份下肢血管造影(排除2份不完整)。
  • 16条肢体(23.2%)为pDVA候选者(理想=7,可能=9)。
  • pDVA候选者截肢前干预次数显著少于非候选者(1.50±0.73 vs 2.61±2.57,P=0.007)。
  • pDVA候选者踝下GLASS分级显著高于非候选者(1.81±0.40 vs 0.86±0.41,P<0.0001),股腘GLASS分级显著低于非候选者(0.73±1.10 vs 2.43±1.71,P<0.0001),两组GLASS分期无显著差异(P=0.368)。

关键数值与推荐

  • 理想候选者:至少1条胫动脉通畅、足部无靶血管、无近端病变。
  • 可能候选者:至少1条胫动脉通畅伴外周动脉疾病、足部无靶血管、近端病变适合腔内治疗。
  • 不适用:无通畅胫动脉、广泛外周动脉疾病或足部存在适合旁路的动脉靶血管。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Percutaneous deep venous arterialization (pDVA) has emerged as a new modality for limb salvage in patients with chronic limb threatening ischemia (CLTI) and no standard option for revascularization. The proportion of patients facing major amputation who are eligible for this technology remains unknown. This study aims to provide a real-life estimate of patient eligibility for pDVA to reduce major amputations. METHODS: Electronic medical records of 100 consecutive patients with peripheral arterial disease (PAD) who underwent major amputation of 106 limbs were reviewed. Angiograms performed ≤6 months before amputation were assessed by two vascular surgeons. Disease severity was categorized using the Global Limb Anatomic Staging System (GLASS) and patients were classified as ideal, possible, or not candidates for pDVA. Ideal candidates had ≥1 patent tibial artery, no target in the foot, and no proximal disease. Possible candidates had ≥1 patent tibial artery with PAD, no target in the foot, and proximal disease amenable to endovascular therapy. Patients were not eligible if there was no patent tibial artery, extensive PAD, or an arterial target in the foot for bypass. RESULTS: Of 106 limbs reviewed, 35 (33%) did not undergo angiography ≤6 months before amputation because of infection (n = 14), advanced tissue loss (n = 10), failed revascularizations (n = 8), advanced limb ischemia (n = 2), and refusing revascularization (n = 1). Thus, 69 lower extremity angiograms (2 incomplete excluded) in 68 patients were analyzed. A total of 15 patients with 16 limbs (23.2%) were identified as candidates for pDVA (ideal = 7, possible = 9). There were no differences in demographics between the two groups, but candidates for pDVA were less likely to have hyperlipidemia and congestive heart failure than those who were not candidates. The pDVA candidates underwent significantly fewer interventions before major amputation compared to patients who were not candidates (1.50 ± 0.73 vs. 2.61 ± 2.57, P = 0.007). Angiographically, patients who were pDVA candidates had significantly higher Inframalleolar GLASS grades (1.81 ± 0.40 vs. 0.86 ± 0.41, P < 0.0001) but lower Femoropopliteal Glass grades (0.73 ± 1.10 vs. 2.43 ± 1.71, P < 0.0001) than patients who were not candidates. There was no significant difference in GLASS stage between these two groups (P = 0.368). After mean follow-up of 48 months, there was no difference in mortality between both groups (40% vs. 32.1%, P = 0.567). CONCLUSIONS: Among patients considered for revascularization, 23.2% had favorable angiography and 14.7% could have benefited for pDVA as a new therapeutic modality for limb salvage. 33% of major amputations were performed for clinically-deemed unsalvageable CLTI.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Satam K, Aboian E, Huttler J, et al. Eligibility of Patients with Chronic Limb Threatening Ischemia for Deep Venous Arterialization. Ann Vasc Surg. 2022. PMID: 35589034. doi:10.1016/j.avsg.2022.04.051

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。